Sex: F
Vaccine: VARZOS
Symptoms: Vaccination failure
Clinical narrative: herpes zoster of left eye; post herpetic neuralgia/painful symptoms and chronic pain; The vaccine did not prevent shingles; a severe vesicular rash, which was diagnosed as herpes zoster; Information has been received from a lawyer referring to a female patient of unknown age. Information about concurrent condition, history condition and concomitant medication was not reported. On or around 28-NOV-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX) (date not reported), the patient suffered herpes zoster of her left eye and post herpetic neuralgia. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events herpes zoster of her left eye and post herpetic neuralgia was considered to be not recovered and causal relationship was assessed as related.   The lawyer considered the events herpes zoster of her left eye and post herpetic neuralgia to be disability.  Upon internal review, the event herpes zoster of her left eye was determined to be medically significant.  Follow up information has been received from a lawyer regarding a case in litigation referring to the female patient of unknown age. On or around 28-NOV-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles. The vaccine did not prevent shingles and the patient subsequently contracted a persistent strain of herpes zoster or shingles. On or about 18-APR-2013, the patient was treated for the onset of a severe vesicular rash, which was diagnosed as herpes zoster. The patient was prescribed prednisone, valacyclovir hydrochloride (VALTREX) and hydrocodone bitartrate (+) acetaminophen (VICODIN) for management of her painful symptoms and chronic pain. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events herpes zoster and vaccination failure was not reported. The lawyer considered the events to be related to zoster vaccine live (ZOSTAVAX).